WallStreetZenWallStreetZen

How to Buy Guardant Health Stock

Guardant Health Inc

Guardant Health, Inc. , a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally.

Guardant Health stock last closed at $29.73, up 1.26% from the previous day, and has increased 31.37% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.44 percentage points. Guardant Health stock is currently +88.05% from its 52-week low of $15.81, and -19.74% from its 52-week high of $37.04.

As of Nov 12, 2024, there are 123.55M shares of GH outstanding. The market capitalization of GH is $3.67B. In the past 24 hours, 1.92M GH shares were traded.

How to Buy Guardant Health Stock

Wondering how to invest in Guardant Health stock? Here's how.
  1. Decide where to buy Guardant Health stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Guardant Health stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit funds into your brokerage account: Pick your method of payment and add your info.
  4. Analyze Guardant Health stock: The Guardant Health ticker symbol is GH. Is Guardant Health stock a good investment? Should you buy shares of GH? How do GH's underlying business fundamentals look? Do top analysts think Guardant Health is a good buy? Why has GH's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if GH is a good stock to buy).
  5. Execute your GH trade: Decide if you will purchase GH shares at the current market price or use a limit order to purchase GH stock at a given price.
  6. Keep an eye on your GH position: Create a watchlist to monitor your investment in Guardant Health shares.

Step 1: Decide where to buy Guardant Health stock

You will need a brokerage account to access the NASDAQ market and buy GH stock.

A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best online stock brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global markets: From Tech to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've picked your brokerage, you need to fill out some personal info so you are able to invest in GH stock today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal details to create a new brokerage account.
  1. Submit your info by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've finished signing up on the best stock trading app, you need to deposit funds:

Check out the video below for more details depositing funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Guardant Health stock

After you have decided on the best place to buy Guardant Health stock, it's absolutely critical to analyze their stock prior to buying, so you actually wrap your head around the risk and opportunity.

Guardant Health quick stats

GH Price
$29.73
1w %
26.4%
1y %
31.37%
5y %
-59.58%
P/E
-6.95x
P/B
-61.12x
P/S
5.28x
PEG
N/A
Revenue
$692.26M
Earnings
-$512.41M
Fore. Rev. Growth
11.24%
Fore. Earn. Growth
N/A
Market Cap
$3.67B
Next Earnings
N/A
Next Dividend
N/A

GH Overview

WallStreetZen was built to help everyday investors do better fundamental analysis.

You can see all of the due diligence checks on GH's stock page.

Is GH stock overvalued?

You can use many financial metrics, analyses, models, and charts to gauge GH's intrinsic value.

You can access additional valuation research on GH's stock here.

GH Financial Overview

Passed Health Checks:

  • GH has cash burn of 274360000. It has sufficient cash and short-term investments to cover this for at least one year.
  • GH has $999.07M in cash and short term investments. This is enough to cover its annual cash burn of $274.36M.
  • There are more short-term assets than short-term liabilities on the GH balance sheet.

Failed Health Checks:

  • Total GH debt is still negative.
  • There are more long-term liabilities than short-term assets on the GH balance sheet.
  • GH profit margin has gone up by 0.07 percentage points in the past year, but the company is still unprofitable.
  • GH debt to equity ratio of -26.6 is negative.

Do Wall Street analysts think it's a good time to buy Guardant Health stock

Out of 14 Equities analysts who research GH, the consensus analyst rating on Guardant Health is a Strong Buy

Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.

Latest GH Analyst Ratings

David Westenberg, a top 10% analyst from Piper Sandler maintains GH with a strong buy rating and raises their GH price target from $30.00 to $34.00, on Aug 13, 2024.

Piper Sandler's David Westenberg raised their price target on Guardant Health (NASDAQ: GH) by 13.3% from $30 to $34 on 2024/08/13. The analyst maintained their Strong Buy rating on the stock.

Westenberg's price target hike and model update on Guardant Health were part of a post-print review of names in their Healthcare (Labs and Genomic Tools) sector coverage area.

Guardant Health reported its Q2 2024 earnings on 2024/08/07.

Earnings Report

For Q2 20204, Guardant Health reported:

  • Loss per share of $0.48, which beat the Zacks Consensus Estimate of $(0.57) and, by 28.4%, Q2 2024's $(0.67).
  • Revenue of $177.24M, which beat the Zacks Consensus Estimate by 9.45% and Q2 2023's $137.15M by 29.2%.

For FY 2024, management guided:

  • Revenue of $690M to $700M, representing Y/Y growth of 22% to 24%, up from the prior $675M to $685M.

Co-founder & Co-CEO Helmy Eltoukhy commented: "We had another strong quarter driven by solid volume growth, particularly for biopharma, and continued improvements to Guardant360 reimbursement.

“We also reached major milestones across our oncology business with the upgrades of Guardant360 onto our Smart Liquid Biopsy platform, a revolutionary platform that combines genomics with epigenomics, and of Guardant360 TissueNext to identify more treatment options for patients with advanced cancer.

"Additionally, our COSMOS study was recently published in Clinical Cancer Research and submitted to MolDx for Medicare reimbursement of CRC surveillance.

"We look forward to continuing this momentum throughout the remainder of the year as we deliver on our mission of giving us all more time free from cancer.”

Co-Founder & Co-CEO AmirAli Talasaz added: "FDA approval of our Shield blood test for first-line colorectal cancer screening is a huge victory for Guardant and patients.

“Commercial launch of Shield and CMS coverage make our blood-based screening option accessible to more than 45M Medicare beneficiaries.

"Shield offers a more pleasant way to stay up to date with colorectal cancer screening and detect the disease early, when it is more easily treated.”

Patrick B Donnelly, a top 17% analyst from Citigroup maintains GH with a strong buy rating and raises their GH price target from $40.00 to $45.00, on Aug 8, 2024.

Dan Brennan, a top 16% analyst from TD Cowen maintains GH with a strong buy rating and raises their GH price target from $41.00 to $42.00, on Aug 8, 2024.

Alex Nowark, a top 34% analyst from Craig-Hallum maintains GH with a buy rating and raises their GH price target from $28.00 to $37.00, on Aug 8, 2024.

Mark Massaro, a top 28% analyst from BTIG maintains GH with a strong buy rating and raises their GH price target from $45.00 to $50.00, on Jul 30, 2024.

You can dive deeper into what analysts are forecasting on the Guardant Health stock forecast page.

GH Momentum

SMA10
25.67
SMA20
23.33
SMA50
23.31
SMA100
26.61
SMA200
24.12
MACD
1.61
MACD Signal
0.61
MACD Histogram
1.01
RSI
76.87
Stochastic %K
67.37
Stochastic %D
68.52
StochRSI %K
100
StochRSI %D
100

GH Performance Numbers

Last year, GH revenue was $692.26M. In the past five year, GH's revenue has gone up by 30.29% per year. This was faster than the Diagnostics & Research industry average of 9.55%.

Find out more about GH's earnings and revenue performance here.

Who is buying/selling GH?

Over the past year, insiders at GH have bought more shares than they have sold.

Darya Chudova, Chief Technology Officer of GH, was the latest GH insider to sell. They sold $116,702.00 worth of GH stock on Nov 4, 2024.

Research more about who owns GH stock here.

Does GH provide a stable income stream?

No, Guardant Health doesn't provide an income stream by paying out dividends.

What others are saying about GH

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Execute your GH trade

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.

Press the Open button and your broker will place the order.

If you need additional help investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Keep an eye on your GH position

Now that you own some GH shares, you'll want to stay up-to-date on your stock purchase.

Create a watchlist to track your GH stock.

GH Feed

How to Buy Stock in Guardant Health

To summarize, here are the 6 steps you need to take to buy Guardant Health stock right now:

  1. Decide where to buy Guardant Health stock
  2. Open a brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Guardant Health stock
  5. Execute your GH trade
  6. Keep an eye on your GH position

If you require a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get updates on your investment in Guardant Health, add GH to your watchlist by clicking the button below.

NASDAQ: GH
$29.73+0.37 (+1.26%)
Updated Nov 12, 2024
Open eToro Account
NASDAQ: GH
$29.73+0.37 (+1.26%)
Updated Nov 12, 2024
Open eToro Account

FAQ

How much does it cost to buy one Guardant Health share?

As of Nov 12, 2024, it costs $29.73 to buy one share of Guardant Health stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.336 shares of GH.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Guardant Health stock?

According to 14 Wall Street analysts who monitor Guardant Health, their consensus recommendation is to buy Guardant Health stock.

What is the best way to buy Guardant Health stock?

One way to place an order for Guardant Health stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.